Results 51 to 60 of about 9,080 (215)
Endobronchial mucormycosis: A rare clinical entity diagnosed by endobronchial cryobiopsy
Respiratory Medicine Case Reports, 2022 Mucormycosis is a rare fungal infection caused by fungi of the order Mucorales. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas pulmonary mucormycosis is a rare manifestation in patients with ...
Awais Bajwa +5 more
doaj +1 more source
Treatment of Aspergillosis. [PDF]
, 2018 Infections caused by Aspergillus spp. remain associated with high morbidity and mortality. While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive aspergillosis (IA) in those patients most at risk for infection ...
Hoenigl, Martin, Jenks, Jeffrey D
core +1 more source
Journal of Clinical Laboratory Analysis, EarlyView.Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh +13 more
wiley +1 more source
Brazilian Journal of Infectious Diseases, 2012 Pulmonary mucormycosis is a very rare clinical condition in patients without underlying risk factors. A limited number of cases have been reported in predominantly elderly patients; history of smoking appears to be a common feature. A case of non-smoking
Lu Zhang +4 more
doaj +1 more source
Radiology Case Reports, 2023 The development of pulmonary artery pseudoaneurysm (PAP) secondary to pulmonary mucormycosis (PM) is exceedingly rare. Without immediate intervention, PAPs can result in life-threatening hemorrhage as these weakening vessels are prone to rupture.
Kelly Trinh, Duc Le, Thomas Callahan
doaj +1 more source
Inhibition of EGFR Signaling Protects from Mucormycosis
mBio, 2018 Mucormycosis is a life-threatening, invasive fungal infection that is caused by various species belonging to the order Mucorales. Rhizopus species are the most common cause of the disease, responsible for approximately 70% of all cases of mucormycosis ...
Tonya N. Watkins +11 more
doaj +1 more source
Transplant Infectious Disease, EarlyView.Among patients referred for allogeneic hematopoietic cell transplantation with pulmonary opacities, lung biopsy provided a diagnosis in 72% of procedures and altered management in 51%. Despite a 7% major complication rate, lung biopsy frequently clarified noninfectious etiologies when bronchoscopy was inconclusive.
Sergio Rodriguez‐Rodriguez +8 more
wiley +1 more source
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study) [PDF]
, 2016 Isavuconazonium sulfate (Cresemba; Astellas Pharma Inc.), a water-soluble prodrug of the triazole antifungal agent isavuconazole, is available for the treatment of invasive aspergillosis (IA) and invasive mucormycosis.
Akhtar, Shahzad +6 more
core +1 more source
An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients
Transplant Infectious Disease, EarlyView.ABSTRACT Invasive fungal infections (IFI) remain a significant infection‐related complication in solid organ transplant recipients (SOTRs), the incidence of which has not changed overtime. With a focus on studies and data published after 2019, this narrative review provides an update on the epidemiology and prevention of IFIs in SOTRs and highlights ...
Tina Marinelli, Shahid Husain
wiley +1 more source
Disseminated pulmonary mucormycosis with concomitant tuberculosis infection in a diabetic patient
International Journal of Mycobacteriology, 2020 Patients with diabetes are often susceptible to various opportunistic infections such as tuberculosis and mucormycosis. However, the occurrence of both these infections simultaneously is rare.
Priyamvadha Ramesh +3 more
doaj +1 more source